Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Lonza Announces Expansion of its HPAPI Capacity for ADC Payload Manufacturing
Introduction Lonza announced an expansion of its highly potent API HPAPI capacity for the specific support of Antibody Drug Conjugate ADC payload manufacturing Features The new suites will be capable to handle a variety of highly potent products with occupational expo
Bioanalytical Systems, Inc (BASi) Plans to Expand its GLP Toxicology Facility in Indiana
Introduction Bioanalytical Systems, Inc BASi plans to break ground on the expansion of its GLP toxicology facility on its 52acre campus in Mt Vernon, Indiana, near Evansville Features The expansion of GLP toxicology will double the facilitys current capacity for
Novo Nordisk to Establish Manufacturing Site in California
Introduction Novo Nordisk announced the establishment of a manufacturing site in Fremont, California, US to develop and produce stem cellbased therapies Features The site will develop stemcellbased therapies within type 1 diabetes and other serious chronic diseases The announcement follows the signing of a longterm lease on a Good Manuf...
Boehringer Ingelheim Begins US$99 million New Tablet Production Facility
Introduction Boehringer Ingelheim had begun construction of a new production facility for innovative drugs with an investment of US$99 million Features The new production facility will focus on the development activities for drugs in tablet form and manufacture them acros
Amgen to Construct Next-generation Biomanufacturing Plant with US$200 million in Rhode Island
Introduction Amgen announced the groundbreaking of its new nextgeneration biomanufacturing plant with US$200 million at its West Greenwich, Rhode Island USA campus Features The new plant will use Amgens proven nextgeneration biomanufacturing capabilities
Boehringer Ingelheim Announces US$260 million Investment into new Biologicals Development Center
Introduction Boehringer Ingelheim announced a US$260 million investment into a new Biological Development Center BDC at the companys Research and Development site in Biberach, Germany Features The BDC will help to maximise by integrating Biologicals analytical an
Wuxi Biologics to Invest US$60 million to Build a Biologics Manufacturing Unit in Singapore
Introduction Wuxi Biologics plans to invest US$60 million in establishing a stateoftheart biologics manufacturing facility in Singapore Features The manufacturing facility will be arranged with singleuse bioreactors at the nextgeneration facility It is major
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility
Introduction Lonza opens the worlds largest dedicated cellandgenetherapy facility in Pearland, Greater Houston, TX USA Features The facility was built in anticipation of the rising demand from developers of cell and gene therapies and with the mission
Sterling Pharma Solutions to Invest US$8 million in Pilot Plant Facility at its UK Site
Introduction Contract Development and Manufacturing Organisation CDMO, Sterling Pharma Solutions is investing US$8 million into its pilot plant facility at its UK site Features The facility will enhance the pilot plants capacity by 33 per cent and increas
WuXi Biologics Plans to Invest US$ 382 million to Build Largest Biomanufacturing Facility Centre in Ireland
Introduction WuXi Biologics announces to make an investment of US$382 million to construct a largest Biomanufacturing facility centre in Ireland using singleuse biologics approach Features The Biomanufacturing facility centre is proposed to get constructed on the
